Dr. Antonio Calles 🫁🚭· @Tony_Calles · X·· 14 小时前评分70
正文 · 原文
📖 A new chapter in SCLC therapy has been written by @sands_jacob
💥 DeLLphi-305 sets a new standard of care in maintenance after induction chemo-io for patients with ES-SCLC
#ESMO26 @myESMO
145 浏览 · 4 赞 · 2 转发 · 0 回复
会议摘要
LBA3按 Presidential Symposium I 对上
Tarlatamab plus durvalumab (durva) vs durva as 1L maintenance (1LM) therapy following durva, platinum, and etoposide (1L durva + EP) in extensive-stage small cell lung cancer (ES-SCLC): Primary analysis of the phase 3 DeLLphi-305 trial
https://esmocongress.esmo.org来源：Dr. Antonio Calles 🫁🚭 · x.com